Fernando Bazán

8.5k citations

68 papers · 6.7k indexed · 5 hit papers · h-index 20

Impact in

Immunology top 0.5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immune Response and Inflammation
- IL-33, ST2, and ILC Pathways
Immunology and Allergy top 0.5%
- Allergic Rhinitis and Sensitization

Papers in

Oncology 44
- Cancer Treatment and Pharmacology 15
- HER2/EGFR in Cancer Research 14
- PARP inhibition in cancer therapy 14
Physiology 6
- Calcium signaling and nucleotide metabolism 6

Co-authors: Robert A. Kastelein René de Waal Malefyt Yong-Jun Liu S. V. Antonenko Norimitsu Kadowaki Stephen Ho Satish Menon Pedro A. Reche
Journals: Annals of Oncology (6 papers)The Breast (5 papers)Journal of Clinical Oncology (5 papers)European Journal of Cancer (2 papers)Genomics (2 papers)
Partner nations: France United States Spain

In The Last Decade

Fernando Bazán

67 papers receiving 6.5k citations

Hit Papers

5 papers align trajectories log scale

Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival 2009 · 510 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2009 Nature
2002 Nature Immunology
2001 The Journal of Experimental Medicine
1997 Immunity
1994 Annual Review of Immunology

Peers

Countries citing papers authored by Fernando Bazán

Since Specialization

Citations

This map shows the geographic impact of Fernando Bazán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fernando Bazán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fernando Bazán more than expected).

Fields of papers citing papers by Fernando Bazán

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fernando Bazán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fernando Bazán. The network helps show where Fernando Bazán may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Fernando Bazán, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Fernando Bazán Line = papers co-authored together Fernando Bazán links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	LBA17 Primary endpoint results of SYNERGY, a randomized phase II trial, first-line chemo-immunotherapy trial of durvalumab, paclitaxel, and carboplatin with or without the anti-CD73 antibody oleclumab in patients with advanced or metastatic triple-negative breast cancer (TNBC) Annals of Oncology ·Laurence Buisseret, Delphine Loirat, Choi-Wan Chan, Kevin Punie, Christian Maurer, Véronique Debien, Ana Sofia Gonçalves, François Ghiringhelli, D. P. Taylor, Florian Clatot, Qingtian Liang, J-M Ferrero, Hervé Bonnefoi, J-L. Canon, François P. Duhoux, Fernando Bazán, Paulus Kristanto, Evandro de Azambuja, Michail Ignatiadis, Martine Piccart	2022	7
2	Cardiotoxicity is mitigated after a supervised exercise program in HER2-positive breast cancer undergoing adjuvant trastuzumab Frontiers in Cardiovascular Medicine ·R. Indira, زبير مكاوي, Thomas Stanfield Allen, Malika Bouhaddi, Pauline Roux, Bruno Degano, Marion Chatot, Elsa Curtit, Laura Mansi, Jihan Guo, Fernando Bazán, L. Chaigneau, Erion Dobi, Jean-François Hamel, Déwi Vernerey, Xavier Pivot, Fabienne Mougin	2022	16
3	Study of the SARS-CoV-2-specific immune T-cell responses in COVID-19-positive cancer patients European Journal of Cancer ·Laura Mansi, Laurie Spehner, Étienne Daguindau, Kévin Bouiller, Hamadi Almotlak, Ulrich Stein, Adeline Bouard, Stéfano Kim, SeonjuKo, Marine Jary, Jean-François Hamel, Angélique Vienot, Charlée Nardin, Fernando Bazán, Quentin Lepiller, Virginie Westeel, Olivier Adotévi, Christophe Borg, Marie Kroemer	2021	17
4	Real-life study of BRCA genetic screening in metastatic breast cancer Annals of Oncology ·Jean-François Hamel, Cristian Villanueva, Antoine Thiery-Vuillemin, Luigi Mansi, Philippe Montcuquet, زبير مكاوي, L. Chaigneau, Fernando Bazán, Hamadi Almotlak, Erion Dobi, Pierre (1580?-1630?). Auteur du texte Mainfray, SeonjuKo, P Watkin, Sophie Paget‐Bailly, Aurélia Meurisse, Alizar Alizar, Christopher A. Hunter, Xavier Pivot, Elsa Curtit	2017	3
5	In the Era of Genomics, Should Tumor Size Be Reconsidered as a Criterion for Neoadjuvant Chemotherapy? The Oncologist ·Xavier Pivot, Laura Mansi, L. Chaigneau, Philippe Montcuquet, Antoine Thiery-Vuillemin, Fernando Bazán, Erion Dobi, Kathryn Gaetke, 福瀬達郎, Muhamad Shafiq Mohd Ali, Chuyi Huang, Farid Jamshidian, Phillip G. Febbo, Christer Svedman, Sophie Paget‐Bailly, Franck Bonnetain, Т. П. Ванченко	2015	19
6	Pylephlebitis as a Complication of Diverticulitis New England Journal of Medicine ·Fernando Bazán, 弘渡邊	2015	7
7	Évaluation économique de l’utilisation en routine du test Oncotype DX® dans la prise en charge des cancers du sein en Franche-Comté Bulletin du Cancer ·Virginie Nerich, Elsa Curtit, Fernando Bazán, Philippe Montcuquet, Cristian Villanueva, L. Chaigneau, L. Cals, زبير مكاوي, Erion Dobi, Edward F. Kramer, Marie‐Paule Algros, H. Andrew Schwartz, Smarajit Manna, Samuel Limat, ZHAMBALOVA S.G., Xavier Pivot	2014	6
8	Litopedion Cirugía Española ·Fernando Bazán, Aleksandar Radosevic, Stephanie N. Vaughn, Juan A. Sánchez	2014	0
9	Discordances in Estrogen Receptor Status, Progesterone Receptor Status, and HER2 Status Between Primary Breast Cancer and Metastasis The Oncologist ·Elsa Curtit, Virginie Nerich, Laura Mansi, L. Chaigneau, L. Cals, Cristian Villanueva, Fernando Bazán, Philippe Montcuquet, زبير مكاوي, Sophie Perrin, Marie‐Paule Algros, Xavier Pivot	2013	73
10	Radiología del carcinoma renal Radiología ·Fernando Bazán, 弘渡邊	2013	3
11	Phase II trial of paclitaxel and uracil–tegafur in metastatic breast cancer. TEGATAX trial The Breast ·Cristian Villanueva, L. Chaigneau, Armelle Dufresne, Anne Vuillemin, Ulrich Stein, Martin Demarchi, Fernando Bazán, Trang Huyen Thi Nguyen, Xavier Pivot	2011	1
12	Discordance in early breast cancer for tumour grade, Estrogen Receptor, Progesteron Receptors and Human Epidermal Receptor-2 status between core needle biopsy and surgical excisional primary tumour The Breast ·Véronique Lorgis, Muhamad Shafiq Mohd Ali, Cristian Villanueva, L. Chaigneau, Antoine Thiery-Vuillemin, Thierry Nguyen, Martin Demarchi, Fernando Bazán, Kathryn Gaetke, 权太范, 義春植木, P. Bontemps, Xavier Pivot	2011	59
13	Metastatic gallbladder adenocarcinoma with signet-ring cells: A case report Journal of Medical Case Reports ·Fernando Bazán, Juan F. Sánchez, Stephanie N. Vaughn, Aleksandar Radosevic, K. Hayakawa, Flavio Zuccarino, Lara Pijuán, Ko-Yu Hung	2011	7
14	Sequential taxane and anthracycline-containing neoadjuvant regimens: The sequential order impact The Breast ·Antoine Thiery-Vuillemin, Antonio Llombart‐Cussac, L. Chaigneau, Cristian Villanueva, Fernando Bazán, Philippe Montcuquet, Márcia Silva Pituba Freitas, DJJ Waugh, Muhamad Shafiq Mohd Ali, Xavier Pivot	2010	7
15	Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival Nature ·Martin Schwickart, Xiaodong Huang, Jennie R. Lill, Jinfeng Liu, Ronald E. Ferrando, Dorothy French, Heather Maecker, Karen O’Rourke, Fernando Bazán, Jeffrey Eastham‐Anderson, Yue Peng, David Dornan, David C.S. Huang, Vishva M. Dixit Hit paper breakdown →	2009	510
16	Human epithelial cells trigger dendritic cell–mediated allergic inflammation by producing TSLP Nature Immunology ·Vassili Soumelis, Pedro A. Reche, Holger Kanzler, Wei Yuan, Yevhen Oleksandrovych Severyn, Bernhard Homey, Michel Gilliet, Seham Mostafa Quotb, S. V. Antonenko, P.A. Tatchell, Kathleen M. Smith, Daniel M. Gorman, Sandra Zurawski, Giovanni Pezzulo, Satish Menon, Terri McClanahan, René de Waal Malefyt, Fernando Bazán, Robert A. Kastelein, Yong-Jun Liu Hit paper breakdown →	2002	1717
17	Subsets of Human Dendritic Cell Precursors Express Different Toll-like Receptors and Respond to Different Microbial Antigens The Journal of Experimental Medicine ·Norimitsu Kadowaki, Stephen Ho, S. V. Antonenko, René de Waal Malefyt, Robert A. Kastelein, Fernando Bazán, Yong-Jun Liu Hit paper breakdown →	2001	1580
18	IGIF Does Not Drive Th1 Development but Synergizes with IL-12 for Interferon-γ Production and Activates IRAK and NFκB Immunity ·Douglas S. Robinson, Kazuko Shibuya, Alice Mui, Francesca Zonin, Erin Murphy, Диоманде Мусса Исмаэл, Suzanne B. Hartley, Satish Menon, Rob Kastelein, Fernando Bazán, Anne O’Garra Hit paper breakdown →	1997	620
19	Mouse T Cell Membrane Proteins Rt6−1 and Rt6−2 Are Arginine/Protein Mono(ADPribosyl)transferases and Share Secondary Structure Motifs with ADP-ribosylating Bacterial Toxins Journal of Biological Chemistry ·Friedrich Koch‐Nolte, David L. Petersen, Sriram Balasubramanian, Friedrich Haag, Dominik Kahlke, Smith Dh, Robert Kastelein, Fernando Bazán, Heinz‐Günter Thiele	1996	122
20	The CD40 Antigen and its Ligand Annual Review of Immunology ·Jacques Banchereau, Fernando Bazán, Dominique Blanchard, Francine Brière, Jean‐Pierre Galizzi, Cees van Kooten, 重憲青木, F Rousset, Sem Saeland Hit paper breakdown →	1994	1059

About Fernando Bazán

Fernando Bazán is a scholar working on Oncology, Physiology, Cancer Research, Reproductive Medicine and Immunology, having authored 68 papers that have together received 6.7k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (15 papers), HER2/EGFR in Cancer Research (14 papers), PARP inhibition in cancer therapy (14 papers), Toxin Mechanisms and Immunotoxins (9 papers), Breast Cancer Treatment Studies (8 papers), Calcium signaling and nucleotide metabolism (6 papers), Ovarian cancer diagnosis and treatment (6 papers) and BRCA gene mutations in cancer (5 papers). The work is most often cited by research in Immunology (3.9k citations), Immunology and Allergy (938 citations), Dermatology (1.2k citations), Physiology (282 citations) and Oncology (1.4k citations). Fernando Bazán has collaborated with scholars based in France, United States and Spain. Frequent co-authors include Robert A. Kastelein, René de Waal Malefyt, Yong-Jun Liu, S. V. Antonenko, Norimitsu Kadowaki, Stephen Ho, Satish Menon, Pedro A. Reche, Sem Saeland and Francine Brière. Their work appears in journals such as Annals of Oncology, The Breast, Journal of Clinical Oncology, European Journal of Cancer and Genomics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact